Hong Kong Wireless Telecom Stock News

ESG recognition puts Fosun International in focus Fosun International (SEHK:656) is back on investors' radar after receiving the Certificate of Excellence in Environmental, Social and Governance Reporting from the Hong Kong Management Association, highlighting the depth of ESG integration in its group-wide strategy. See our latest analysis for Fosun International. The ESG recognition arrives after a volatile period, with a 1 day share price return of 7.5% lifting Fosun International to...

Plover Bay Technologies (SEHK:1523) just released its 2025 results, reporting higher revenue, net income and earnings per share, alongside increased dividends and a proposed spin off and Nasdaq listing of its connectivity subsidiary. See our latest analysis for Plover Bay Technologies. The strong 2025 update, higher ordinary and special dividends, and the planned Nasdaq spin off come after a 24.1% 1 month share price return and a 45.1% 3 month share price return, while the 1 year total...

Horizon Robotics (SEHK:9660) is back in focus as investors weigh very strong recent automotive AI revenue growth in relation to expectations for the 23 March 2026 earnings release and potential new OEM design wins in China. See our latest analysis for Horizon Robotics. At the latest share price of HK$8.21, Horizon Robotics has seen short term share price pressure, with a 7 day return of 7.75% and year to date share price return of 8.68%. The 1 year total shareholder return of 1.08% points to...

Recent environmental mandates and power rationing in China have capped Aluminum Corporation of China (SEHK:2600) domestic output, pushing the producer to focus on integrated bauxite-to-smelter projects in Indonesia and confronting EU carbon rules. See our latest analysis for Aluminum Corporation of China. At a latest share price of HK$14.14, Aluminum Corporation of China has a 90 day share price return of 34.8% and a very large 1 year total shareholder return, suggesting momentum has been...

CLP Holdings Limited has released its audited full-year 2025 results, reporting revenue of HK$88,018 million and net profit of HK$10,667 million, both lower than the prior year, alongside earnings per share of HK$4.14 from continuing operations. Despite weaker earnings, the Board raised the total annual dividend to HK$3.20 per share and advanced its transition plans through new renewable projects, battery storage expansion, and the planned divestment of the Jhajjar coal-fired plant in...

What the EU approval could mean for Hansoh Pharmaceutical Group (SEHK:3692) The European Commission’s approval of Hansoh Pharmaceutical Group (SEHK:3692)’s Aumolertinib Mesylate Tablets for specific advanced non small cell lung cancer patients takes Ameile and Aumseqa beyond China and into a major new market. This decision, following a positive view from the European Medicines Agency’s Committee for Medicinal Products for Human Use, adds an EU indication for both first line EGFR mutated NSCLC...

The Hong Kong government recently raised stamp duty on residential properties valued above HK$100,000,000 to 6.5% and outlined plans to bring REITs under mutual-market access while potentially exempting some non-residential property transfers from stamp duty. These policy moves could reshape how developers like Hang Lung Properties balance high-end residential exposure with participation in an evolving REIT and commercial property framework. We’ll now examine how the higher stamp duty on...

SUNeVision Holdings (SEHK:1686) is back in focus after reporting half year results to December 31, 2025, with higher sales, net income and earnings per share, supported by demand for premium data centre capacity. See our latest analysis for SUNeVision Holdings. The latest results land after a strong run in the share price, with a 90 day share price return of 32.42% and a year to date gain of 41.60%, even though the 1 year total shareholder return is 21.68% lower. That mix points to momentum...

Yangtze Optical Fibre and Cable recently announced it will showcase its latest AI‑oriented optical connectivity solutions at MWC Barcelona 2026, including a dedicated March 4 launch event for its hollow‑core fibre technology. This focus on hollow‑core fibre, which is designed to deliver lower latency, higher transmission efficiency and improved signal quality, highlights YOFC’s bid to support next‑generation ultra‑high‑speed data and AI computing networks. We’ll now examine how this...

WuXi XDC Cayman (SEHK:2268) just expanded its ADC platform reach as Earendil Labs secured an exclusive global license to the WuXiTecan-2 payload-linker technology, structured with upfront, milestone and royalty economics. See our latest analysis for WuXi XDC Cayman. The Earendil Labs agreement, which highlights WuXi XDC Cayman’s ADC and payload platform, comes as the shares trade at HK$63.15, with a 1 day share price return of 8.23%, a 30 day share price return of 2.02%, and a 1 year total...

Xinyi Glass Holdings (SEHK:868) has put fresh numbers on the table for FY 2025, with first half revenue of C¥9.8b and basic EPS of C¥0.23, setting the tone for how the rest of the year might shape up. The company has seen revenue move from C¥10.9b in the first half of 2024 to C¥9.8b in the latest half, while EPS has shifted from C¥0.59 to C¥0.23. These shifts sit against trailing twelve month EPS of C¥0.62 on revenue of C¥20.8b. With trailing net margin at 13.1% versus 15.1% a year earlier,...

Xiaomi has taken its tariff and royalty dispute to India's Supreme Court, challenging a tribunal ruling on how certain payments tied to imports should be taxed. The case centers on whether royalty payments linked to technology and brand use should be added to the customs value of imported components. The outcome could shape future tax treatment for contract manufacturing arrangements used by Xiaomi and other multinational producers in India. Xiaomi, traded as SEHK:1810, is contesting this...

Why the Crescent Biopharma partnership matters for Sichuan Kelun-Biotech Biopharmaceutical The new collaboration between Crescent Biopharma and Sichuan Kelun-Biotech Biopharmaceutical (SEHK:6990) on next generation oncology drugs, including joint clinical trials, is drawing fresh attention from investors to Kelun-Biotech's pipeline and funding position. See our latest analysis for Sichuan Kelun-Biotech Biopharmaceutical. At the latest share price of HK$387.4, Sichuan Kelun-Biotech...

MiniMax Group stock moves after sharp month-long rally MiniMax Group (SEHK:100) has drawn fresh attention after a sharp move in its share price over the past month, prompting investors to reassess the newly listed AI foundation model developer. See our latest analysis for MiniMax Group. The latest pullback, including a 3.17% 1 day share price return decline and 21.29% 7 day share price return decline, comes after a 56.45% 30 day and 121.30% year to date share price return. This suggests...

Recent share move and business snapshot Ascentage Pharma Group International (SEHK:6855) has seen its share price move recently, with a 1 day return of about 1.4% and a decline of roughly 26.9% over the past 3 months, drawing attention to its clinical stage biotech profile. See our latest analysis for Ascentage Pharma Group International. Looking beyond the latest move, the share price has recorded a 4.9% decline over the past month and a 26.9% decline over the past quarter, while the 1 year...

JPMorgan’s upgrade of Cathay Pacific Airways (SEHK:293), which followed the expiry of its buyback plan on 24 February 2026, has put fresh attention on the airline’s balance sheet, cash generation, and sizeable aircraft commitments. See our latest analysis for Cathay Pacific Airways. At a share price of HK$14.06, Cathay Pacific’s recent 7 day share price return of 10.53% and 90 day share price return of 16.58% sit alongside a 1 year total shareholder return of 46.56%. This suggests momentum...

Grand Pharmaceutical Group (SEHK:512) has drawn investor attention after posting annual revenue of HK$11,704.979 million and net income of HK$2,079.449 million, putting fresh focus on how its diversified healthcare business is currently valued. See our latest analysis for Grand Pharmaceutical Group. At a share price of HK$7.83, Grand Pharmaceutical Group has seen short term share price pressure, with a 90 day share price return decline of 4.74%. However, its 1 year total shareholder return of...

Full year 2025 results and what changed Xinyi Solar Holdings (SEHK:968) has released full year 2025 results showing sales of CNY 20,861.16 million and net income of CNY 844.53 million, both lower than the previous year. This is likely shaping current investor sentiment. See our latest analysis for Xinyi Solar Holdings. The share price has reacted to the weaker full year 2025 results, but still shows a 13.07% year to date share price return and a 7.45% 90 day share price return. However, the 3...

Earlier this week, Lenovo announced Premier Support Plus for Servers, its highest-tier, AI-driven enterprise support for ThinkSystem and ThinkAgile servers, and expanded its ThinkEdge portfolio with new rugged, AI-ready edge computing devices, including the SE10n Gen 2, SE30n Gen 2, SE60n Gen 2, and the SE50a Panel PC. Taken together, these launches highlight Lenovo’s push to pair AI-enabled infrastructure with premium, proactive support services aimed at always-on, mission-critical...

On 23 February 2026, Fosun International received the "Certificate of Excellence in Environmental, Social and Governance Reporting" from the Hong Kong Management Association, recognizing its ESG reporting quality and climate-related disclosure efforts. This award underlines how Fosun’s “Create IMPACT” sustainable development strategy has embedded transparency, climate action, and governance into its core business approach. We’ll now examine how Fosun’s strengthened ESG reporting and climate...

CLP Holdings (SEHK:2) has just posted its FY 2025 first half numbers, with revenue of HK$42.9b and basic EPS of HK$2.23, setting the tone for how its earnings story is evolving. The company has seen revenue move from HK$44.1b in 1H 2024 to HK$46.9b in 2H 2024 and HK$42.9b in 1H 2025, while EPS has gone from HK$2.36 to HK$2.29 and then HK$2.23 over the same periods. This puts the focus squarely on how margins are holding up through the latest results. See our full analysis for CLP...

If you are wondering whether Geely Automobile Holdings is attractively priced or not, this article will walk you through what the current share price might be implying about its value. The stock last closed at HK$16.31, with a 7 day return of 4.3% decline, a 30 day return of 1.3% decline, a year to date return of 10.4% decline, a 1 year return of 12.4% decline and a 3 year return of 66.1% alongside a 5 year return of 27.7% decline. This gives a mixed picture for investors weighing recent...

Latest Earnings Snapshot Nine Dragons Paper (Holdings) (SEHK:2689) has reported H1 2026 results that keep the recent turnaround in focus, with trailing twelve month revenue at C¥66.997b and basic EPS at C¥0.83 alongside a 252% year-on-year rise in reported earnings and a net profit margin of 4.9% versus 1.5% a year earlier. The company has seen half year revenue move from C¥28.885b in H2 2024 to C¥29.776b in H2 2025. Basic EPS went from C¥0.10 in H1 2025 to C¥0.28 in H2 2025, setting up a...

What Meituan’s 2025 Loss Guidance Means for Investors Meituan (SEHK:3690) has issued earnings guidance for 2025, flagging an expected loss of about CN¥23.3b to CN¥24.3b, compared with a profit of roughly CN¥35.8b in 2024. The company links this swing to an anticipated operating loss of around CN¥6.8b to CN¥7b in its Core Local Commerce segment and to higher spending on overseas expansion, which it frames as a response to intense industry competition. See our latest analysis for...